Limited Offer
Microbial Biofilms
Challenges and Advances in Metabolomic Study
- 1st Edition - June 10, 2023
- Editors: Sanket Joshi, Dibyajit Lahiri, Rina Rani Ray, MubarakAli Davoodbasha
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 7 1 5 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 7 1 6 - 8
Microbial Biofilms: Challenges and Advances in Metabolomic Study is a volume in the Advances in Biotechnology and Bioengineering Series. The volume covers the metabolomic char… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteMicrobial Biofilms: Challenges and Advances in Metabolomic Study is a volume in the Advances in Biotechnology and Bioengineering Series. The volume covers the metabolomic characteristics of bacterial biofilms and examines the techniques used in the analysis of the metabolomics of the biofilm, its formation, and related infections. The book includes the metabolomics study of various types of biofilms and details new strategies in targeting metabolic pathways for inhibiting the biofilm.
The book also describes various types of metabolomics studies like metabolomics of oral biofilm and metabolomics of biofilm by nosocomial microbes. It also points out the recent advancements on various aspects of metabolomics studies pertaining to biofilms, related infections, their pathogenesis, and present-day treatment strategies.
Microbial Biofilms: Challenges and Advances in Metabolomic Study
is a helpful resource to scientists and researchers engaged in biofilm studies, precisely on the metabolomic changes at molecular level occurring in the participating microorganisms. It is also fascinating and thought provoking for the clinicians and health professionals actively involved in the treatment of biofilm mediated chronic infections, since it depicts the pathogenic consequences of the small molecular interactions of the metabolites in biofilm.- Discusses recent trends in biofilms research
- Details newer strategies in treating the biofilm by targeting metabolic pathways
- Covers chronic infections caused by biofilm and their metabolomics studies
- Examines various analytical aspects on the metabolomics study of biofilm as well as how metabolomics regulate the formation of the biofilm
- Incorporates relevant case studies
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- Preface
- Chapter 1. Microbial biofilms: issues and challenges
- 1. History and introduction
- 2. Denotation of biofilm
- 3. Biofilm matrix
- 4. Network of biofilm
- 5. Phases in biofilm formation
- 6. Role of biofilm
- 7. Supremacy of microbes in biofilm
- 8. Detrimental effect of biofilm
- 9. Mechanism of action in a biofilm network
- 10. Antibiotic resistance by biofilm
- 11. Antibiofilm approaches
- 12. Conclusion
- Chapter 2. Genetics of microbial biofilm development
- 1. Introduction
- 2. Quorum sensing
- 3. Genetic control of biofilm formation
- 4. Genes required for various stages of biofilm formation in different bacteria
- 5. Biomathematical modeling: the genetic basis of biofilm development
- 6. CRISPR-based functional analysis of biofilm-forming genes in bacteria
- 7. Conclusion
- Chapter 3. Introduction on genomic analysis of biofilms
- 1. Introduction
- 2. Biofilm formation
- 3. Extracellular polymeric substances
- 4. Quorum sensing
- 5. Antibiotic resistance
- 6. Central line-associated bloodstream infections
- 7. Model of biofilm infection
- 8. Identification of genes and proteins
- 9. Docking and combinatorial library
- 10. Advanced strategies to combat biofilms
- Chapter 4. Metabolomic study of biofilm-forming natural microbiota of oral biofilm
- 1. Introduction
- 2. Formation of biofilm in the buccal cavity
- 3. Defining metabolome
- 4. Metabolomics of biofilms
- 5. Studying biofilm production by Staphylococcus aureus, Fusobacterium nucleatum, and Streptococcus mutans using a specific metabolomic approach
- 6. Conclusion
- 7. Future prospects
- Chapter 5. From symbiosis to dysbiosis in gut-consequence includes metabolic syndrome
- 1. Introduction/keyhole view of gut dysbiosis and metabolic syndrome
- 2. The gut microbiome—our body's largest endocrine organ
- 3. What is symbiosis? How and why does it become dysbiosis
- 4. Current scenario—gut health imbalance and metabolic syndrome
- 5. What is the role of diet in gut symbiosis?
- 6. Move a little to get closer to gut symbiosis!
- 7. Sleep well to reap the benefits of gut symbiosis
- 8. Stress is harmful even to our gut microbiome!
- 9. What is my take-home message?
- Chapter 6. Metabolomic study of biofilm-forming natural microbiota of skin biofilm
- 1. Introduction
- 2. Skin and biofilm production
- 3. Metabolites of skin biofilms
- 4. Natural microbiota of skin biofilms
- 5. Therapeutic strategies to combat biofilm formation
- 6. Future of metabolomics in cosmetics and skin care
- Chapter 7. Metabolomic study of biofilm-forming natural microbiota of vaginal biofilm
- 1. Introduction
- 2. Natural microbiota of vagina
- 3. Metabolome of vagina
- 4. Bacterial vaginosis—pathogenesis
- 5. Metabolome alteration and biofilm formation in bacterial vaginosis
- 6. Diagnosis and treatment for bacterial vaginosis
- Chapter 8. Metabolome analysis for host–microbiota interactions
- 1. Introduction
- 2. Use of metabolic networks of bacteria for studying metabolic communications
- 3. Construction of metabolic networks from annotated genomes
- 4. GEM application in gut microbiota modeling
- 5. Dysbiosis simulation and therapies by use of metabolic networks
- 6. Conclusion
- Chapter 9. Multispecies metabolomics interactions resulting in the development of resistance
- 1. Introduction
- 2. Formation of multispecies biofilm
- 3. Exopolysaccharides
- 4. Extracellular proteins
- 5. Extracellular DNA
- 6. Mechanisms for multispecies biofilm formation
- 7. Quorum sensing signal molecules
- 8. Extracellular polymeric substances
- 9. Biofilm-regulating genes
- 10. Metabolomics in biofilm
- 11. Microbial interaction in multispecies biofilms
- 12. Competitive interaction
- 13. Cooperative interaction
- 14. Horizontal gene transfer
- 15. Other interaction
- 16. General mechanism of multispecies biofilms for antibiotic resistance
- 17. Penetration power of antibiotic
- 18. Persisters
- 19. Efflux pumps
- 20. Antibiotic-degrading enzymes
- 21. Adaptive response
- 22. Multispecies interactions
- 23. Conclusion and future prospects
- Chapter 10. Natural phytochemicals: a potential alternative antibiofilm agent
- 1. Introduction to biofilms—formation and habitat
- 2. Phytochemicals, types, examples, and their varied uses
- 3. Quorum sensing and biofilm inhibitors from phytochemicals
- 4. Biofilm-imposed challenges
- 5. Phytochemical mechanism for inhibition
- 6. Future perspective of novel phytochemical strategies
- 7. Conclusion
- Chapter 11. Medical devices–associated biofilm infections and challenges in treatment
- 1. Introduction
- 2. Medical devices and their uses
- 3. Major threatening consequences of biofilm formation on medical devices
- 4. Molecular mechanism behind biofilm formation on medical devices
- 5. Problems in the diagnosis of medical device–associated biofilm infections
- 6. Novel approaches for combating biofilms on medical devices
- 7. Conclusion
- Chapter 12. NMR-based metabolomics study of microbial biofilm
- 1. Introduction
- 2. Bacterial biofilm
- 3. Steps involved in biofilm formation
- 4. Molecular analysis of biofilm formation
- 5. Genomic analysis of the bacterial biofilms
- 6. Analysis of bacterial biofilm using NMR-based metabolomics
- 7. Metabolite assays by NMR
- 8. In vitro metabolite profiling of microbial biofilm
- 9. Difference between NMR metabolomics of planktonic and biofilm modes of growth
- 10. In Pseudomonas
- 11. In Staphylococcus
- 12. In Salmonella
- 13. In Acinetobacter baumannii
- 14. In oral plaque-forming bacteria
- 15. Evaluation of fast 2D NMR for metabolomics
- 16. 1D, 2D, and solid-state NMR techniques for metabolomics
- 17. Conclusions
- Chapter 13. Isotope labeling LC-MS for metabolomics of biofilm study and tracer-based biofilm metabolomics analysis
- 1. Introduction
- 2. Stable isotopes in metabolomics
- 3. Strategies used in stable isotope labeling to assist metabolomics using LC-MS
- 4. Liquid chromatography–mass spectrometry
- 5. LC-MS in metabolomics of biofilm
- 6. Tracer-based biofilm metabolomics analysis
- 7. Conclusion
- Chapter 14. Lipidomics profiling of microbial biofilm
- 1. Introduction
- 2. Why should we concerned about biofilms?
- 3. What is lipidomics?
- 4. Importance of lipidomics in biofilms
- 5. Lipid nomenclature
- 6. Extraction method
- 7. Separation technique
- 8. Mass spectrometry–based lipidomics analysis
- 9. Application in dental plaque, Candida albicans, vaginal biofilm
- Chapter 15. Functional metabolomics approaches in determining the inhibition of biofilm
- 1. Introduction
- 2. Formation of biofilm
- 3. What is metabolomics?
- 4. Metabolic remodulation triggers biofilm formation
- 5. Inhibition of biofilm
- 6. Prevention of biofilm formation through targeting quorum sensing mechanism
- 7. Metabolomics in drug targeting
- 8. Metabolomics based on nuclear magnetic resonance
- 9. Comparison of NMR-and MS-based metabolomics
- 10. Determination of biofilms using metabolomics based on nuclear magnetic resonance
- 11. Effect of xylitol and fluoride on metabolome profile of oral biofilm
- 12. Metabolic dysregulation of Staphylococcus aureus biofilm by carnosol
- 13. Conclusion
- Chapter 16. Reprogramming the metabolomics of biofilms
- 1. Introduction
- 2. Data analysis
- 3. Pathway and network analysis of metabolomic data
- 4. Methodologies for reprogramming metabolomics
- Chapter 17. Dysbiosis of microbiome: a risk factor for cancer, metabolic and inflammatory diseases
- 1. Introduction
- 2. Host—microbiota interaction
- 3. Microbiota—health and diseased condition
- 4. Healthy microbial profile—bacteriotherapy
- 5. Fecal transplantation
- 6. Conclusions
- Chapter 18. Strategies to reduce microbial biofilm in medical prosthesis and other devices
- 1. Introduction
- 2. Tooth implant
- 3. Bone implant
- 4. Pacemaker
- 5. Naturally dissolving suture
- 6. Synthetic skin/tissue/ligament
- 7. Prevention and control
- 8. Discussion
- 9. Conclusion
- Chapter 19. Targeting microbial biofilms using genomics-guided drug discovery
- 1. Introduction
- 2. Genomic approaches to study biofilm formation
- 3. Transcriptomic approaches to study biofilm formation
- 4. Proteomic approaches to study biofilms
- 5. Drug discovery
- 6. Genomics-guided drug discovery
- Chapter 20. Biofilms: a sociomicrobiological nexus
- 1. Introduction to biofilms
- 2. Stages and complexity of a biofilm
- 3. Competition in biofilms
- 4. Coordination and cooperation in biofilms
- 5. Role of mutations in biofilm
- 6. Genetic study of biofilm formation in vitro by the introduction of genes such as green fluorescent protein
- 7. Conclusion
- Chapter 21. In silico and in vivo methods for designing antibiofilm agents against Pseudomonas aeruginosa and Staphylococcus aureus
- 1. Introduction
- 2. Biofilms
- 3. Biofilms and human diseases
- 4. Antibiofilm strategies
- 5. Antibiofilm studies
- 6. Recent advances
- Chapter 22. Biofilm: a threat to medical devices
- 1. Introduction
- 2. Biofilm formation strategy on medical devices
- 3. Biofilm and abiotic medical implants
- 4. Role of biofilm in disease
- 5. Prevention and control strategy for biofilm on medical devices
- 6. Early detection of biofilm formation in medical implants
- 7. Treatment approach for biofilm colonization on medical devices
- 8. Conclusion
- Chapter 23. Biofilm formation in acute and chronic respiratory infections caused by nosocomial gram-negative bacteria
- 1. Introduction
- 2. Biofilms: what are they?
- 3. Biofilm biogenesis
- 4. Biofilms and nosocomial infections
- 5. Role of biofilms in nosocomial infections with reference to chronic respiratory infections
- 6. Current inhalation treatments for chronic infections caused by pulmonary biofilms
- 7. Conclusion
- Acknowledgments
- Index
- No. of pages: 452
- Language: English
- Edition: 1
- Published: June 10, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780323957151
- eBook ISBN: 9780323957168
SJ
Sanket Joshi
DL
Dibyajit Lahiri
RR
Rina Rani Ray
MD